CATALYST PHARMACEUTICALS, INC. (CPRX)
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Address
355 ALHAMBRA CIRCLE
CORAL GABLES, FL 33134
Founded
2002
Number of Employees
167
Website
http://www.catalystpharma.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | $12,092 | $6,911 | - | - | $9,501 |
| Average Price | - | - | - | - | - | - | - | $5.48 | $6.91 | - | - | $5.92 |
| # Shares Purchased | - | - | - | - | - | - | - | 2,208,292 | 1,000,000 | - | - | 1,604,146 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | 265.3% | 189.4% | - | - | 237.7% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | 37.3% | - | - | 34.5% |
| Excess Total Return | - | - | - | - | - | - | - | 233.6% | 152.1% | - | - | 203.2% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | 98% | 97% | - | - | 95% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
People also followed
Never miss an email alert when insiders at CPRX make a trade.
Creating a free account takes less than one minute